Radiotherapy is an independent prognostic marker of favorable prognosis in non ‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab

ConclusionPrevious RT was an independent prognostic marker of favorable prognosis after nivolumab administration and improved the response rate to nivolumab treatment. Previous RT was clinically identified to have a synergistic effect with nivolumab treatment, increasing the response rate and improving the outcome of patients with advanced NSCLC.

Source: Thoracic Cancer - March 18, 2019 Category: Cancer & Oncology Authors: Ou Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto, Atsuto Mouri, Yu Miura, Ayako Shiono, Fuyumi Nishihara, Yoshitake Murayama, Shin ‐ei Noda, Shingo Kato, Kunihiko Kobayashi, Hiroshi Kagamu Tags: ORIGINAL ARTICLE Source Type: research